New Jersey 2024-2025 Regular Session

New Jersey Assembly Bill A3300

Introduced
1/9/24  

Caption

"HOPE Initiative Act;" requires establishment of public awareness campaign to educate citizens about dangers and causes of, and appropriate responses to, heroin and opioid addiction.

Impact

The legislation recognizes the prevalent issue of the opioid crisis within New Jersey and underscores that all citizens must be equipped with knowledge to recognize and act upon signs of addiction, both in themselves and others. The campaign will focus on dispelling myths surrounding heroin and opioid users, illustrating how addiction can affect anyone, and promoting a narrative that integrates assistance and recovery into community health strategies. In doing so, the act aims to shift public perception and reduce stigma towards those seeking help.

Summary

Assembly Bill A3300, also known as the 'HOPE Initiative Act', mandates the establishment of a public awareness campaign aiming to educate citizens about the dangers, causes, and appropriate responses related to heroin and opioid addiction. The act designates the Division of Mental Health and Addiction Services to lead this initiative in collaboration with various organizations, including the Governor’s Council on Alcoholism and Drug Abuse and the Partnership for a Drug-Free New Jersey. It emphasizes the need for a coordinated approach to reach all sectors of the population, targeting not just users but also medical professionals, families, and educators.

Contention

The bill includes detailed provisions for information dissemination, including the use of various media channels such as print, television, social media, and educational events tailored to target different audiences. One notable point of contention is the recognition of legitimate opioid prescriptions versus abuse, seeking to foster public understanding while condemning misuse. This aspect is vital as it aims to prevent potential backlash against legitimate medical prescriptions while simultaneously combatting the ongoing epidemic of opioid misuse and addiction.

Companion Bills

NJ A2410

Carry Over "HOPE Initiative Act;" requires establishment of public awareness campaign to educate citizens about dangers and causes of, and appropriate responses to, heroin and opioid addiction.

Previously Filed As

NJ A2410

"HOPE Initiative Act;" requires establishment of public awareness campaign to educate citizens about dangers and causes of, and appropriate responses to, heroin and opioid addiction.

NJ AB182

Heroin and Opioid Public Education (HOPE) Act.

NJ AB2174

Heroin and Opioid Public Education (HOPE) Act.

NJ A520

Establishes public awareness campaign about Pregnant Women/Women With Dependent Children initiative and Maternal Wrap Around program.

NJ AR105

Relative to Opioid Abuse Awareness.

NJ A3825

Requires DHS to establish public awareness campaign about period poverty.

NJ A1983

Requires DHS to establish public awareness campaign about period poverty.

NJ HB2709

Establishing fentanyl poisoning awareness week for public middle schools and high schools to educate students on the abuse of and addiction to fentanyl and other opioids.

NJ A409

Establishes public awareness campaign concerning the dangers of leaving children unattended in and around motor vehicles.

NJ HB3285

Relating to programs and initiatives to prevent and respond to opioid addiction, misuse, abuse, and overdose and identify and treat co-occurring substance use disorders and mental illness.

Similar Bills

NJ A2410

"HOPE Initiative Act;" requires establishment of public awareness campaign to educate citizens about dangers and causes of, and appropriate responses to, heroin and opioid addiction.

CA AB182

Heroin and Opioid Public Education (HOPE) Act.

CA AB2174

Heroin and Opioid Public Education (HOPE) Act.

NJ A1681

Requires health insurance companies to cover lead screenings for children 16 years of age or younger.

NJ S1450

Requires health insurance companies to cover lead screenings for children 16 years of age or younger.

NJ S741

Requires health insurance companies to cover lead screenings for children 16 years of age or younger.

NJ A2433

Requires health insurance companies to cover lead screenings for children 16 years of age or younger.

NJ A188

Requires prescriptions for animals to be issued in name of animal owner; prohibits unnamed persons from possessing prescribed drugs; and requires Prescription Monitoring Program to include information about controlled substances prescribed by veterinarians.